文献速递MDS 与骨髓增殖性肿瘤

比较MPN患者与医生报告的症状负担识别差异——德国MPN研究组(GSG-MPN)的个体内分析

Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN).
PubMed 文献 · Leukemia · 2025-02-25

该研究对德国MPN研究组生物登记库中3979例MPN患者进行回顾性分析,个体内比较同一时间点医生与患者报告的症状负担,计算Cohen kappa评估一致性,并用线性回归和校正Cox模型分析症状严重度影响因素及对生存的影响。结果显示所有症状患者报告频率均高于医生,一致性低,且严重症状负担患者生存较差。

要点

  • MPN患者症状负担高,且不随时间或细胞减灭治疗而减轻。
  • 所有症状患者报告频率均高于医生报告,一致性低。
  • 严重症状负担患者生存较症状较轻者差。

核心结论

  • MPN症状负担评估不充分,患者报告结局工具需纳入临床常规。

研究设计与样本

  • 回顾性分析德国MPN研究组生物登记库中3979例MPN患者,个体内比较同一时间点医生与患者报告的症状负担。

主要发现

  • MPN患者症状负担高,既不随时间下降也不随细胞减灭治疗下降。
  • 所有症状患者报告频率均高于医生报告。
  • 患者与医生报告的一致性低,考虑更高患者症状严重度阈值时一致性仅轻微改善。
  • 严重症状负担患者生存较症状较轻者差。

关键数值与推荐

  • 采用Cohen kappa评估患者与医生报告的一致性。
  • 采用线性回归识别基线症状严重度的影响因素,并计算校正Cox模型分析症状负担对生存的影响。

临床怎么用

  • 原文结论认为MPN症状负担评估不充分,患者报告结局工具需纳入临床常规。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myeloproliferative neoplasms (MPN) are associated with a variety of symptoms that severely impact patients' quality of life and ability to perform daily activities. Recent studies showed differences in the perception of physician- versus patient-reported symptom burden. However, studies directly comparing patient- and physician-reported ratings are lacking. Here, a retrospective analysis on symptom burden of 3979 MPN patients of the Bioregistry of the German Study Group for MPN was conducted to intra-individually compare physician and patient reports collected at the same time. Cohen's kappa was calculated to assess the degree of agreement between patient and physician reports. Factors influencing baseline symptom severity were identified using linear regression and adjusted Cox models were calculated to investigate the effect of symptom burden on survival. MPN patients had a high symptom burden, which neither decreased over time nor upon cytoreductive therapy. All symptoms were more frequently reported by patients compared to physicians. Agreement remained low and only slightly improved when considering a higher threshold for patient symptom severity. Patients with severe symptom burden had inferior survival compared to patients with less severe symptoms. Assessment of symptom burden in MPN is therefore insufficient and patient-reported outcome tools need to be implemented into clinical routine.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Manz K, Heidel FH, Koschmieder S, et al. Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN). Leukemia. 2025. PMID: 40000843. doi:10.1038/s41375-025-02524-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。